Invesaro

Stocks SLGL Financial statements

Financial statements

Sol-Gel Technologies Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Sol-Gel Technologies Ltd. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue0.170.1322.98.7731.33.881.5511.519.4
Research and development1725.828.140.627.920.412.723.517.822.8
General and administrative3.7365.58.2811.18.457.457.375.754.18
Operating income-20.8-31.6-33.5-26-30.22.96-16.2-29.3-12-7.54
Pre-tax income-31.6-32.2-24.6-29.33.22
Income tax0.0300000
Net income-20.8-31.6-32.2-24.6-29.33.22-14.9-27.2-10.6-6.13
EBITDA-20.4-31.2-32.8-25.1-29.33.84-15.7-29-11.8-7.43
EPS, basic32.7149.7517.84-12.49-12.881.39-6.44-10.01-3.79-2.19
EPS, diluted32.7149.7517.84-12.49-12.881.39-6.44-10.01-3.79-2.19
Shares, basic (weighted)0.630.631.81.972.282.332.332.712.792.79
Shares, diluted (weighted)0.630.631.81.972.282.382.332.712.792.79

Balance sheet

FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents75.025.339.417.1220.112.47.5119.511
Short-term investments56.74121.71.718.6820.54.4313
Receivables4.122.1513.10.060.383.61.97
Other current assets0.471.522.991.291.070.81.512.793.771
Total current assets8.310.56655.853.457.143.141.231.327
Property, plant and equipment0.82.312.62.311.821.050.660.430.20.14
Lease right-of-use assets2.041.91.50.881.721.431.03
Other non-current assets0.060.010.06
Total assets1115.369.761.359.269.246.645.335.829.9
Accounts payable0.670.532.921.711.20.770.250.151.270.74
Accrued liabilities3.620.911.033.253.251.691.262.051.062.91
Short-term debt37.365.3
Total current liabilities41.667.24.96.515.9611.73.334.525.296.17
Lease liabilities1.371.30.810.051.210.880.5
Total liabilities42.3685.778.848.3113.64.426.6477.11
Paid-in capital32.342.5191204232233235258259259
Retained earnings-63.7-95.3-127-152-181-178-193-220-231-237
Shareholders' equity-31.3-52.763.952.550.855.642.238.628.922.8
Total equity-31.3-52.763.952.550.855.642.238.628.922.8
Total liabilities and equity1115.369.761.359.269.246.645.335.829.9
Shares outstanding0.630.631.912.062.322.332.3327.92.792.79

Cash flow statement

FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-20.8-31.6-32.2-24.6-29.33.22-14.9-27.2-10.6-6.13
Depreciation and amortization0.360.470.760.890.950.880.560.340.230.11
Stock-based compensation0.953.974.652.551.220.691.531.860.790.08
Change in receivables-1.19-0.461.65-4.121.97-18.312.67.8600
Change in payables2.51-2.493.030.94-0.545.62-8.31.470.780.82
Cash from operations-18.5-24.1-23.5-22.5-25.2-7.69-9.48-17.7-13.90.32
Capital expenditures-0.39-1.93-1.05-0.6-0.45-0.14-0.17-0.13-0-0.05
Purchases of investments-71.8-38.7-32.3-6.72-10-23.20-14.1
Sales and maturities of investments15.154.351.526.82.9211.815.95.51
Cash from investing-0.39-5.94-54.716-2.6919.91.7-9.7426.7-8.58
Stock issued0.0400.150.330.020.2700.01
Cash from financing202878.810.626.50.840.0221.800.01
Exchange rate effect-0.010.050.03-0.05-0.01-0.06
Net change in cash1.11-1.980.654.09-1.4913-7.64-5.7412.8-8.44
Free cash flow-18.9-26-24.5-23.1-25.7-7.83-9.66-17.9-13.90.28
Income taxes paid00.010.0300

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $66.85 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin-38.9%Operating income / revenue.
EBITDA margin-38.3%EBITDA (operating income + depreciation and amortization) / revenue.
Net margin-31.6%Net income / revenue.
FCF margin1.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin1.7%Cash from operations / revenue.
Return on equity (ROE)-23.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-18.6%Net income / average total assets.
Return on invested capital (ROIC)-56.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue117.6%Research and development expense / revenue.
Stock-based pay / revenue0.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.2%Capital expenditures / revenue.
D&A / revenue0.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y68.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y70.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y17.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-20.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-18.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-14.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-16.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-13.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-12.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y6.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y4.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio4.37xCurrent assets / current liabilities.
Quick ratio4.21x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio3.89x(Cash + short-term investments) / current liabilities.
Liabilities / assets23.8%Total liabilities / total assets.
Working capital$20.8MCurrent assets - current liabilities.
Tangible book value$22.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.59xRevenue / average total assets.
Fixed asset turnover113xRevenue / average property, plant and equipment.
Receivables turnover6.97xRevenue / average receivables.
Days sales outstanding52 days365 x average receivables / revenue.
Capex / operating cash flow14.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$2.19Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$2.19Net income per basic share, as reported (split-adjusted).
Revenue per share$6.96Revenue / diluted weighted shares.
FCF per share$0.10Free cash flow / diluted weighted shares.
Operating cash flow per share$0.12Cash from operations / diluted weighted shares.
Book value per share$8.19Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$8.19Tangible book value / shares outstanding.
Cash per share$8.61(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$187.8MShare price x shares outstanding.
Enterprise value$163.8MMarket cap + total debt - cash - short-term investments.
P/S9.69xMarket cap / revenue.
P/B8.23xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book8.23xMarket cap / tangible book value, when positive.
P/FCF683xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF583xMarket cap / cash from operations, when positive.
EV/Sales8.45xEnterprise value / revenue.
EV/FCF596xEnterprise value / free cash flow, when both are positive.
FCF yield0.1%Free cash flow / market cap.
Earnings yield-3.3%Net income / market cap (the inverse of P/E).
What was Sol-Gel Technologies Ltd.'s revenue in fiscal 2025?

Sol-Gel Technologies Ltd. reported revenue of $19.4M for fiscal 2025, 68% higher than the year before.

Was Sol-Gel Technologies Ltd. profitable in fiscal 2025?

No. It reported a net loss of $6.1M.

How much free cash flow did Sol-Gel Technologies Ltd. generate in fiscal 2025?

Cash from operations of $322.0K minus capital expenditures of $47.0K left free cash flow of $275.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Sol-Gel Technologies Ltd.